Home > Solutions for
Medial EarlySign develops clinical decision support solutions for healthcare providers that add an artificial intelligence (AI) brain to facilitate proactive, outcome-focused care opportunities for patients at high risk for particular medical conditions within a designated time frame. Our platform utilizes cognitive machine learning and advanced algorithms that expose hidden layers of information in standard EHR data, and across thousands of parameters and interrelationships.
We conduct extensive research, build, and refine a unique algorithmic toolset that can detect hidden medical patterns in billions of EHR files. Our AlgoAnalyzer™ interfaces with a healthcare organization’s IT, manages preliminary data handling activities like standardization and normalization, and blends into existing workflows. It hosts our condition-specific AlgoMarker™ risk predictors that deliver actionable insights, and enable the next generation in clinical decision support focusing on outcomes-based care.
Medial EarlySign is at the forefront of transforming clinical laboratories from processing samples and providing accurate lab results, into providing clinical decision support to aid in early diagnosis, personalized intervention, and better disease monitoring. Our Laboratory Information System (LIS) solutions apply machine learning, artificial intelligence, and patients’ lab histories to enable personalized interpretations of clinical laboratory results.
Our AlgoAnalyzer™ solutions for hospital laboratories fully integrate with its existing IT and existing workflows, and manage preliminary data handling activities like standardization and normalization. Laboratories can choose from among our condition-specific AlgoMarker™ risk predictors that trigger “red alerts” for their healthcare colleagues to weigh expediting outcomes-based care for patients at high risk for particular medical conditions. Medial EarlySign’s solutions enhance a laboratory’s role, value, and relationship within any healthcare organization.
Our custom solutions can deliver data-driven, disease-specific predictions that lead to targeted, cost-effective management of patient populations and sub-populations at high risk for particular illnesses. Using partner data together with our AlgoAnalyzer™, AlgoMarker™, and know-how, we enable our customers to build and tailor machine learning-based solutions to identify patients early who are at elevated risk for life-altering medical outcomes.